Comorbidities can contribute to agitation and can make an accurate differential diagnosis challenging. The ongoing development of rapidly acting novel formulations of antiagitation medications, if successful, may facilitate clinical treatment by providing additional options.
Advances in the pathophysiology of bipolar disorder
Bipolar disorder (BD) is a chronic and often severe psychiatric disorder affecting approximately 1–4%of the world population. There are three types of BD, including bipolar I disorder (BD-I), bipolar II disorder (BD-II), and cyclothymic disorder. All three types involve clear changes in mood, energy, and activity levels. Leer texto completo
